肺切除手术后术后呼吸衰竭患者的炎症和组织损伤的时间和空间模式:一个嵌套的病例对照研究
Jay Kormish1,2,3, Tejas Ghuman2,4, Richard Y Liu1,2
1Section of Thoracic Surgery, Department of Surgery, Health Sciences Centre, Winnipeg, MB R3A 1R9, Canada.
International journal of molecular sciences
|June 28, 2023
概括
肺部手术后的术后呼吸衰竭与肺部和血液中的特定炎症和损伤标志物有关. 识别这些生物标志物可以帮助预测和管理胸部手术后的并发症.
科学领域:
- 肺部医学 肺部医学
- 手术重症监护手术重症监护
- 翻译研究是翻译研究.
背景情况:
- 肺切除胸部手术带有严重的术后肺部并发症的风险,如急性呼吸困扰综合征 (ARDS) 和呼吸衰竭.
- 肺切除期间的单肺通风 (OLV) 会增加呼吸器诱导的肺损伤 (VILI),低氧化和再注射损伤的风险.
- 了解局部和全身炎症反应对于管理风险患者至关重要.
研究的目的:
- 为了比较局部 (经过手术和通风的肺) 和全身炎症/损伤标志物的模式,在患有术后呼吸衰竭的患者和没有患有术后呼吸衰竭的患者中.
- 为了确定与肺部手术后呼吸道并发症相关的特定蛋白质生物标志物.
- 探索动脉血生物标志物模式的差异,以及来自通风和手术肺部的支气管膜洗.
主要方法:
- 一个在肺部手术患者的前队列中嵌入的病例控制研究.
- 生物样本 (动脉血,支气管洗) 从患者在OLV前和肺切除后收集.
- 多重免疫试验量化了50种炎症和组织损伤的蛋白质生物标志物.
主要成果:
- 在患有术后呼吸衰竭的患者和匹配的对照者之间,在炎症和组织损伤生物标志物中发现了显著的差异.
- 在动脉血中观察到明显的生物标志物模式,以及来自通风和手术肺部的支气管膜洗.
- 该研究成功地确定了特定的蛋白质生物标志物,使得结果有所不同.
结论:
- 血和肺洗中的生物标志物概况可以区分肺部手术后出现呼吸衰竭的患者.
- 这些发现表明了早期检测和有针对性的干预措施的潜力,以减轻术后肺部并发症.
- 对这些独特的生物标志物模式的进一步研究可能会改善患者管理策略.
相关概念视频
01:27Pneumothorax-II
217
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
217
01:23Acute Respiratory Failure-IV
179
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
179
01:21Acute Respiratory Failure-II
285
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
285
01:30Acute Respiratory Failure-III
232
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
232
01:29Acute Respiratory Failure-V
169
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
169
01:17Pulmonary Cycle: Exhalation
1.6K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K